Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for DGWPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 -31.18M
March 31, 2026 -20.99M
December 31, 2025 -25.24M
September 30, 2025 -21.16M
June 30, 2025 -42.64M
March 31, 2025 -25.19M
December 31, 2024 -21.96M
September 30, 2024 -12.57M
June 30, 2024 7.868M
March 31, 2024 -19.54M
December 31, 2023 -19.85M
September 30, 2023 -13.67M
June 30, 2023 -17.40M
March 31, 2023 -21.81M
December 31, 2022 -22.48M
September 30, 2022 19.57M
June 30, 2022 73.67M
March 31, 2022 -33.43M
December 31, 2021 -100.03M
September 30, 2021 -65.82M
June 30, 2021 12.80M
March 31, 2021 27.48M
December 31, 2020 -213.07M
September 30, 2020 -41.90M
June 30, 2020 -33.34M
Date Value
March 31, 2020 -20.09M
December 31, 2019 -18.92M
September 30, 2019 -17.42M
June 30, 2019 -18.17M
March 31, 2019 -14.92M
December 31, 2018 -22.17M
September 30, 2018 -17.11M
June 30, 2018 -15.96M
March 31, 2018 -19.62M
December 31, 2017 -19.68M
September 30, 2017 -22.67M
June 30, 2017 -19.10M
March 31, 2017 -12.98M
December 31, 2016 -19.05M
September 30, 2016 -18.83M
June 30, 2016 -28.05M
March 31, 2016 -19.14M
December 31, 2015 -28.26M
September 30, 2015 -33.05M
June 30, 2015 -35.61M
March 31, 2015 -89.08M
December 31, 2014 -37.25M
September 30, 2014 -41.84M
June 30, 2014 -32.76M
March 31, 2014 -23.73M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Ottobock SE & Co. KGaA -160.52M
Abbott Laboratories -673.00M
AngioDynamics, Inc. -1.27M
Alphatec Holdings, Inc. -22.72M
AtriCure, Inc. -3.766M